Opiate detoxification under anesthesia: No apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure

被引:39
作者
Pfab, R [1 ]
Hirtl, C [1 ]
Zilker, T [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, Toxicol Abt, D-81675 Munich, Germany
来源
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1999年 / 37卷 / 01期
关键词
D O I
10.1081/CLT-100102407
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Introduction: The new technique for opiate detoxification using anesthesia and high, repetitive doses of opiate-antagonists claims to detoxify addicts without withdrawal symptoms within 24-48 hours. We studied the method with 12 opiate addicts (5 L-polamidone, 4 dihydrocodeine, 3 heroin), using general anesthesia and the antagonists naloxone 0.5 mg/kg and naltrexone > 150 mg. Objective and subjective withdrawal symptoms were measured until urine was free of drugs and patients had no withdrawal symptoms. Thyroid hormones were measured before, during, and after the anesthesia period. Results: All patients had moderate to severe opiate withdrawal symptoms. No detoxification was finished within 48 hours. The dihydrocodeine subjects were compared with conventionally detoxified controls; no difference was seen. The method suppressed thyroid hormones TT3, TT4, and TSH. The study was terminated because of side effects: 1 pulmonary failure and 2 renal failures. All patients survived without sequelae, Conclusion: There is no obvious benefit from this method, whereas the risks are high.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 26 条
[1]   HYPOTHALAMIC REGULATION OF PULSATILE THYROTOPIN SECRETION [J].
BRABANT, G ;
PRANK, K ;
HOANGVU, C ;
HESCH, RD ;
MUHLEN, AV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) :145-150
[2]   OPIOID WITHDRAWAL AND NALTREXONE INDUCTION IN 48-72 HOURS WITH MINIMAL DROP-OUT, USING A MODIFICATION OF THE NALTREXONE-CLONIDINE TECHNIQUE [J].
BREWER, C ;
REZAE, H ;
BAILEY, C .
BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 :340-343
[3]   Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation [J].
Brewer, C .
ADDICTION BIOLOGY, 1997, 2 (03) :291-302
[4]   Opiate detoxification under [J].
Brewer, C .
BRITISH MEDICAL JOURNAL, 1998, 316 (7149) :1983-1984
[5]   2 CASES OF NALOXONE-INDUCED PULMONARY-EDEMA - THE POSSIBLE USE OF PHENTOLAMINE IN MANAGEMENT [J].
BRIMACOMBE, J ;
ARCHDEACON, J ;
NEWELL, S ;
MARTIN, J .
ANAESTHESIA AND INTENSIVE CARE, 1991, 19 (04) :578-580
[6]  
DIBONA GF, 1994, J AM SOC NEPHROL, V4, P1792
[7]   NALTREXONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF OPIOID DEPENDENCE [J].
GONZALEZ, JP ;
BROGDEN, RN .
DRUGS, 1988, 35 (03) :192-213
[8]   REVERSIBLE RENAL-FAILURE FOLLOWING OPIOID ADMINISTRATION [J].
HILL, SA ;
QUINN, K ;
SHELLY, MP ;
PARK, GR .
ANAESTHESIA, 1991, 46 (11) :938-939
[9]   THE NALOXONE TEST FOR OPIATE DEPENDENCE [J].
JUDSON, BA ;
HIMMELBERGER, DU ;
GOLDSTEIN, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :492-501
[10]   Clinical studies of drug addiction, III A critical review of the withdrawal treatments with method of evaluating abstinence syndromes [J].
Kolb, L ;
Himmelsbach, CK .
AMERICAN JOURNAL OF PSYCHIATRY, 1938, 94 :759-799